1. Home
  2. LRMR vs NRIM Comparison

LRMR vs NRIM Comparison

Compare LRMR & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • NRIM
  • Stock Information
  • Founded
  • LRMR N/A
  • NRIM 1990
  • Country
  • LRMR United States
  • NRIM United States
  • Employees
  • LRMR N/A
  • NRIM N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • NRIM Savings Institutions
  • Sector
  • LRMR Health Care
  • NRIM Finance
  • Exchange
  • LRMR Nasdaq
  • NRIM Nasdaq
  • Market Cap
  • LRMR 426.9M
  • NRIM 474.2M
  • IPO Year
  • LRMR N/A
  • NRIM N/A
  • Fundamental
  • Price
  • LRMR $4.02
  • NRIM $79.32
  • Analyst Decision
  • LRMR Strong Buy
  • NRIM
  • Analyst Count
  • LRMR 8
  • NRIM 0
  • Target Price
  • LRMR $19.63
  • NRIM N/A
  • AVG Volume (30 Days)
  • LRMR 1.0M
  • NRIM 24.3K
  • Earning Date
  • LRMR 10-30-2024
  • NRIM 01-23-2025
  • Dividend Yield
  • LRMR N/A
  • NRIM 2.88%
  • EPS Growth
  • LRMR N/A
  • NRIM 22.45
  • EPS
  • LRMR N/A
  • NRIM 5.86
  • Revenue
  • LRMR N/A
  • NRIM $141,590,000.00
  • Revenue This Year
  • LRMR N/A
  • NRIM N/A
  • Revenue Next Year
  • LRMR N/A
  • NRIM $3.03
  • P/E Ratio
  • LRMR N/A
  • NRIM $14.67
  • Revenue Growth
  • LRMR N/A
  • NRIM 12.70
  • 52 Week Low
  • LRMR $3.01
  • NRIM $43.92
  • 52 Week High
  • LRMR $13.68
  • NRIM $91.72
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 26.41
  • NRIM 51.76
  • Support Level
  • LRMR $3.01
  • NRIM $83.29
  • Resistance Level
  • LRMR $6.91
  • NRIM $89.11
  • Average True Range (ATR)
  • LRMR 0.55
  • NRIM 2.54
  • MACD
  • LRMR -0.19
  • NRIM -0.89
  • Stochastic Oscillator
  • LRMR 31.28
  • NRIM 5.84

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.

Share on Social Networks: